Henlius Kicks Off Denosumab Trial

Chinese Firm Doses First Patient In Phase I Trial For Xgeva/Prolia Biosimilar

 
• By David Wallace
  
Clinical Trial
Shanghai Henlius has begun dosing in Phase I trials for denosumab • Source: Shutterstock

More from Biosimilars

More from Products